Nicola Hamilton

2.6k total citations
23 papers, 661 citations indexed

About

Nicola Hamilton is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nicola Hamilton has authored 23 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 9 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nicola Hamilton's work include Cancer Treatment and Pharmacology (5 papers), Neutropenia and Cancer Infections (5 papers) and HER2/EGFR in Cancer Research (5 papers). Nicola Hamilton is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Neutropenia and Cancer Infections (5 papers) and HER2/EGFR in Cancer Research (5 papers). Nicola Hamilton collaborates with scholars based in United States, United Kingdom and Ireland. Nicola Hamilton's co-authors include Clifford A. Hudis, Larry Norton, Donald Ogilvie, Ian D. Waddell, Allan M. Jordan, James R. Hitchin, Helen Small, George Raptis, Emma Fairweather and Stuart Jones and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Nicola Hamilton

23 papers receiving 643 citations

Peers

Countries citing papers authored by Nicola Hamilton

Since Specialization

Citations

This map shows the geographic impact of Nicola Hamilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola Hamilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola Hamilton more than expected).

Fields of papers citing papers by Nicola Hamilton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicola Hamilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola Hamilton. The network helps show where Nicola Hamilton may publish in the future.

Co-authorship network of co-authors of Nicola Hamilton

This figure shows the co-authorship network connecting the top 25 collaborators of Nicola Hamilton. A scholar is included among the top collaborators of Nicola Hamilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicola Hamilton. Nicola Hamilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fluoromethylcyclopropylamine derivatives as potential in vivo toxicophores – A cautionary disclosure 2019 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Helen Small, Kate M. Smith, Alison E. McGonagle, Alexandra Stowell, Dominic I. James, Niall M. Hamilton, Nicola Hamilton, James R. Hitchin, Colin Hutton, Ian D. Waddell, Donald Ogilvie, Allan M. Jordan	1
2	Cell-Active Small Molecule Inhibitors of the DNA-Damage Repair Enzyme Poly(ADP-ribose) Glycohydrolase (PARG): Discovery and Optimization of Orally Bioavailable Quinazolinedione Sulfonamides 2018 ·Journal of Medicinal Chemistry ·Bohdan Waszkowycz, Kate M. Smith, Alison E. McGonagle, Allan M. Jordan, (unknown), Emma Fairweather, (unknown), Niall M. Hamilton, Nicola Hamilton, James R. Hitchin, Colin Hutton, Dominic I. James, Clifford D. Jones, Stuart Jones, Daniel P. Mould, Helen Small, Alexandra Stowell, Julie A. Tucker, Ian D. Waddell, Donald Ogilvie	26
3	Abstract 4705: CTLA4 blockade with HER2-directed therapy (H) yields clinical benefit in women undergoing radiation therapy (RT) for HER2-positive (HER2+) breast cancer brain metastases (BCBM) 2017 ·Cancer Research ·Heather L. McArthur, Kathryn Beal, Darragh Halpenny, (unknown), Shanu Modi, Sujata Patil, Robert J. Young, Thomas Kaley, Taha Merghoub, Christopher A. Barker, Phillip Wong, Nicola Hamilton, Clifford A. Hudis, Jedd D. Wolchok, Larry Norton	12
4	First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to Olaparib 2016 ·ACS Chemical Biology ·Dominic I. James, Kate M. Smith, Allan M. Jordan, Emma Fairweather, (unknown), Nicola Hamilton, James R. Hitchin, Colin Hutton, Stuart Jones, Paul Kelly, Alison E. McGonagle, Helen Small, Alexandra Stowell, Julie A. Tucker, Ian D. Waddell, Bohdan Waszkowycz, Donald Ogilvie	94
5	Abstract 5429: Inhibition of SMARCA2: a novel target for SMARCA4-deficient lung adenocarcinoma 2015 ·Cancer Research ·(unknown), (unknown), Graeme Thomson, Emma Fairweather, (unknown), James R. Hitchin, Nicola Hamilton, Allan M. Jordan, Ian D. Waddell, Donald Ogilvie	1
6	Phase II Study of Paclitaxel Given Once per Week Along With Trastuzumab and Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer 2014 ·Journal of Clinical Oncology ·Chau T. Dang, Neil M. Iyengar, (unknown), Gabriella D’Andrea, Maria Theodoulou, Maura N. Dickler, Shari Goldfarb, Diana Lake, (unknown), Monica Fornier, Theresa Gilewski, Shanu Modi, Devika Gajria, Mary Ellen Moynahan, Nicola Hamilton, Sujata Patil, Maxine S. Jochelson, Larry Norton, José Baselga, Clifford A. Hudis	55
7	A fluorescence-based assay for the apurinic/apyrimidinic-site cleavage activity of human tyrosyl-DNA phosphodiesterase 1 2013 ·Analytical Biochemistry ·Graeme Thomson, Nicola Hamilton, (unknown), Ian D. Waddell, Amanda J. Watson, Donald Ogilvie	9
8	A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors 2013 ·Breast Cancer Research ·Clifford A. Hudis, Charles Swanton, Yelena Y. Janjigian, (unknown), Stephanie Sutherland, (unknown), Sarat Chandarlapaty, Nicola Hamilton, Devika Gajria, James Knowles, Jigna Shah, (unknown), Ernestina Tetteh, Daniel M. Sullivan, Carolina Moreno, Yan Li, Hyo S. Han	85
9	Generation of assays and antibodies to facilitate the study of human 5′-tyrosyl DNA phosphodiesterase 2013 ·Analytical Biochemistry ·Graeme Thomson, Amanda J. Watson, Keith W. Caldecott, (unknown), Paul Depledge, Nicola Hamilton, (unknown), Allan M. Jordan, Christopher J. Morrow, Ali Raoof, Ian D. Waddell, Donald Ogilvie	17
10	Toxoflavins and Deazaflavins as the First Reported Selective Small Molecule Inhibitors of Tyrosyl-DNA Phosphodiesterase II 2013 ·Journal of Medicinal Chemistry ·Ali Raoof, Paul Depledge, Niall M. Hamilton, Nicola Hamilton, James R. Hitchin, (unknown), Allan M. Jordan, (unknown), Alison E. McGonagle, Daniel P. Mould, (unknown), Helen Small, Kate M. Smith, Graeme Thomson, (unknown), Ian D. Waddell, Bohdan Waszkowycz, Amanda J. Watson, Donald Ogilvie	55
11	Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC). 2013 ·Journal of Clinical Oncology ·(unknown), Gabriella D’Andrea, Maura N. Dickler, Shari Goldfarb, Maria Theodoulou, Diana Lake, Monica Fornier, Shanu Modi, (unknown), Elizabeth Comen, Devika Gajria, Mary Ellen Moynahan, Tiffany A. Traina, (unknown), Nicola Hamilton, Sujata Patil, Sarat Chandarlapaty, Clifford A. Hudis, Chau T. Dang	4
12	Novel Steroid Inhibitors of Glucose 6-Phosphate Dehydrogenase 2012 ·Journal of Medicinal Chemistry ·Niall M. Hamilton, Martin D. Dawson, Emma Fairweather, Nicola Hamilton, James R. Hitchin, Dominic I. James, Stuart Jones, Allan M. Jordan, Amanda Lyons, Helen Small, Graeme Thomson, Ian D. Waddell, Donald Ogilvie	53
13	A phase I study of the AKT inhibitor (MK-2206) with concurrent trastuzumab and lapatinib in patients with HER2-positive solid tumors. 2011 ·Journal of Clinical Oncology ·Hyo S. Han, Charles Swanton, Y. Y. Janjigian, Stephanie Sutherland, Sarat Chandarlapaty, (unknown), Nicola Hamilton, (unknown), (unknown), Yan Liang, Dan M. Sullivan, C. Hudis	11
14	A pilot study of Interpersonal Psychotherapy by telephone with cancer patients and their partners 2000 ·Psycho-Oncology ·Jean Donnelly, Alice B. Kornblith, Stewart B. Fleishman, Enid Zuckerman, George Raptis, Clifford A. Hudis, Nicola Hamilton, David Payne, Mary Jane Massie, Larry Norton, Jimmie C. Holland	102
15	High-dose chemotherapy of breast cancer: Current status and developmental strategies 1995 ·European Journal of Cancer ·John Crown, George Raptis, Nicola Hamilton, D. Fennelly, Linda T. Vahdat, Larry Norton	4
16	Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer. 1995 ·PubMed ·Linda T. Vahdat, George Raptis, D. Fennelly, Nicola Hamilton, Lillian Reich, Amy Tiersten, M Harrison, Clifford A. Hudis, Michael P. Moore, Tzy‐Jyun Yao, Larry Norton, John Crown	13
17	High-intensity chemotherapy with peripheral blood progenitor cell support. 1994 ·PubMed ·D. Fennelly, Linda T. Vahdat, Jeffrey Schneider, Lilian Reich, Nicola Hamilton, Thomas B. Hakes, George Raptis, Carolyn Wasserheit, (unknown), (unknown)	8
18	Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer. 1993 ·Journal of Clinical Oncology ·John Crown, (unknown), Linda T. Vahdat, Lilian Reich, Malcolm A.S. Moore, Nicola Hamilton, Jeffrey Schneider, M Harrison, Theresa Gilewski, Clifford A. Hudis	55
19	Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor a randomized trial 1993 ·Cancer ·(unknown), John Crown, Robert J. Motzer, Lilian Reich, Glenn Heller, Michael P. Moore, Nicola Hamilton, Tzy‐Jyun Yao, Robert T. Heelan, Jeffrey Schneider, (unknown), Beryl McCormick, Teresa Gilewski, R J O'Reilly, (unknown), Larry Norton	39
20	High‐Intensity Chemotherapy with Hematopoietic Support in Breast Cancer^a 1993 ·Annals of the New York Academy of Sciences ·John Crown, Linda T. Vahdat, D. Fennelly, Prudence A. Francis, Carolyn Wasserheit, Clifford A. Hudis, (unknown), Jeffrey Schneider, Nicola Hamilton, Teresa Gilewski, Larry Norton	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact